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How patients relate to the experience of their illness has a direct impact over their behavior. We aimed to assess
illness perception in patients with pulmonary tuberculosis (TB) by means of the Brief Illness Perception
Questionnaire (BIPQ) in correlation with patients’ demographic features and clinical TB score.
Our observational questionnaire based study included series of consecutive TB patients enrolled in several countries
from October 2008 to January 2011 with 167 valid questionnaires analyzed. Each BIPQ item assessed one
dimension of illness perceptions like the consequences, timeline, personal control, treatment control, identity,
coherence, emotional representation and concern. An open question referred to the main causes of TB in each
patient’s opinion.
The over-all BIPQ score (36.25 ± 11.054) was in concordance with the clinical TB score (p ≤ 0.001). TB patients
believed in the treatment (the highest item-related score for treatment control) but were unsure about the illness
identity. Illness understanding and the clinical TB score were negatively correlated (p < 0.01). Only 25% of the
participants stated bacteria or TB contact as the first ranked cause of the illness.
For routine clinical practice implementation of the BIPQ is convenient for obtaining fast and easy assessment of
illness perception with potential utility in intervention design. This time saving effective personalized approach may
improve communication with TB patients and contribute to better behavioral strategies in disease control.
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Individuals diagnosed with an illness develop cognitive
models to make sense of their ailment. These percep-
tions are important in guiding coping strategies and
illness-specific behaviors (Broadbent et al. 2006; Petrie
et al. 2002; Petrie et al. 2003). Patients may develop spe-
cific ideas about their disease. Research on illness per-
ceptions may reveal differences between the physician’s* Correspondence: dragica.pesut@mfub.bg.ac.rs
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in any medium, provided the original work is pview and the patient’s view, understanding and reaction
(Bean et al. 2007). Changing patients’ illness perceptions
is possible and it has been shown to improve recovery
following myocardial infarction, and other self regulatory
interventions in conditions such as diabetes mellitus
(Petrie et al. 2002). In AIDS, the changes have improved
patient outcome (Petrie et al. 2003).
Tuberculosis (TB) is a major cause of mortality and
morbidity worldwide, affecting different countries dis-
proportionately (World Health Organization 2011, 2014).
Increasing number of HIV-infected people and the
emergence of drug-resistant strains of M. tuberculosis,
especially in Eastern Europe, make TB control more
complicated (Migliori et al. 2008; Raviglione and SmithOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 TB score components at the beginning of
treatment (0) and after two months at the end of the
continual phase of therapy (2)
TB score item
0 (N0 = 167) 0 (N0 = 93) 2 (N2 = 93)
N° % N° % N° %
1 Cough 133 79.64 73 78.49 55 59.14
2 Hemoptysis 35 20.96 17 18.28 7 7.53
3 Dyspnea 67 40.12 35 37.63 26 27.96
4 Chest pain 61 36.53 31 33.33 15 16.13
5 Night sweats 93 55.69 45 48.39 23 24.73
6 Anemic 56 33.53 27 29.03 13 13.98
7 Tachycardia 62 37.13 31 33.33 15 16.13
8 Auscultation 99 59.28 34 36.56 71 76.34
9 Temperature > 37°C 82 49.10 44 47.31 9 9.68
10 BMI < 18 44 26.35 20 21.51 15 16.13
11 BMI < 16 22 13.17 5 5.37 2 2.15
12 MUAC < 220 55 32.93 19 20.43 20 21.51
13 MUAC < 200 22 13.17 6 6.45 2 2.15
BMI = Body Mass Index; MUAC =Mid Upper Arm Circumference.
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and World Health Organization 2014). Proper infor-
mation for patients and adherence to treatment are espe-
cially important in preventing drug resistance (Stop TB
Partnership and World Health Organization 2014; WHO
2010; World Health Organization 2003). Recently, at-
tempts have been made to identify the TB cases needing
close follow-up to predict unsuccessful treatment out-
come (Hasker et al. 2008; Baussano et al. 2008). Other
studies have revealed that poor communication between
health care staff and TB patients was a key issue under-
lying several causes of default and that TB patients lack
proper information about this disease and its treatment
(Hasker et al. 2010). Since some patients’ reactions are not
fully explained by lack of information, they could be ex-
plained by illness perception, so assessment of this is war-
ranted in routine clinical practice. Behavioral strategies
are required for successful TB control. Ongoing research
over the past 30 years has demonstrated the importance
of illness representations to patients’ behavior (Broadbent
et al. 2006; Petrie et al. 2002; Petrie et al. 2003). Percep-
tions can now be assessed by a number of psychometric
instruments like the Brief Illness Perception Questionnaire
(BIPQ), which has not been used for TB yet.
Methods
Study design and subjects
We aimed to assess illness perception in patients with
pulmonary TB by implementation of the Brief Illness
Perception Questionnaire (BIPQ) in correlation with the
patients’ demographic data, social factors and clinical
score at two time points: i) at the start of treatment, ii)
at the end of the initial phase of treatment (after 2
months).
This observational study included a series of 178 con-
secutive newly diagnosed pulmonary TB patients (World
Health Organization 2003) aged 18 years or older enrolled
at TB hospitals in Europe and Asia between 1 October
2008 and 31 January 2011.
Data were collected by members of the Tuberculosis
Network European Trials Group (TBNET) and allied
researchers from Poland, Portugal, Romania, Serbia,
Slovakia and India, who entered them in Microsoft Excel
worksheets. The ethical board of the coordinating centre
at the University Clinical Centre of Serbia, Belgrade,
approved the study (12/4 B).
Questionnaires
The patients’ clinical questionnaire was created to obtain
demographic (sex, age) and social (marital status, profes-
sion, education) factors, tobacco smoking status and TB
score (the components of the latter are listed in Table 1).
The other one was the original Brief Illness Perception
Questionnaire (BIPQ). After giving informed consent, allthe 178 patients voluntarily completed the questionnaires
at the start of treatment (0-month) for demographic and
social data, symptoms as part of a TB score and the BIPQ.
Medical staff were involved in providing relevant clinical
data related to the TB score. The 167/178 question-
naires were valid, and 93/167 patients were retested after
2-months.TB score
A simple clinical score was developed by Wejse et al.
(2008) for repeated clinical status evaluation of TB pa-
tients during treatment without using advanced technical
equipment. It is a useful clinical index, which is sensitive
to changes during treatment. TB score components in-
cluded self reported symptoms (cough, dyspnea, night
sweats, hemoptysis and chest pain) and signs (anemia:
paleness of conjunctivae at eye-examination; tachycardia:
pulse rate ≥90/min; positive finding at lung ausculta-
tion: any one of the following findings present: crepi-
tation, rhonci, subdued or complete absence of respiratory
sounds; axillary temperature: temperature ≥37.08°C mea-
sured by an electronic thermometer in a closed axillary
fold; body mass index (BMI): height measured using a
meter scale and weight determined at each visit using the
same balance. BMI = weight/(height)2; mid upper arm cir-
cumference (MUAC): measured over biceps of the non-
dominant arm with a non-stretchable measuring tape. We
used original instructions to score (the higher the score,
the more severe clinical form of TB) (Wejse et al. 2008)
and perform statistical analysis.
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The BIPQ is a 9-item questionnaire, used to measure ill-
ness perceptions along the following dimensions: iden-
tity, consequences, timeline, personal control, treatment
control, concern, understanding and emotional represen-
tations (Broadbent et al. 2006). Each dimension is mea-
sured as a single item scored on an 11-point Likert scale,
with higher scores indicating stronger endorsement of that
item. According to the original instructions, summary
score was also calculated by adding all of the BIPQ indi-
vidual items to reflect the overall positivity or negativity of
an individual’s illness perceptions. Finally, the BIPQ in-
cluded an open question aimed to assess patients’ opinion
about the three main causes of their disease in a rank
order (Broadbent et al. 2006). The BIPQ is presented in
Additional file 1.
The BIPQ forward and back-translation process caused
no difficulties. After linguistic validation, BIPQ versions
conceptually and linguistically equivalent to the original
instrument were offered to the patients in their native lan-
guages. Implementation of the BIPQ in research on renal
disease, type 2 diabetes mellitus, myocardial infarction,
asthma, and minor disturbances showed good test retest
validity (Broadbent et al. 2006) and another study led to
its intercultural validation (Bean et al. 2007). The calcu-
lated minimum number of study group participants is 85
(Broadbent et al. 2006).
Data analysis
Data were entered in Microsoft Excel worksheets and
IBM SPSS Statistics 19 was employed for the analysis. WeFigure 1 The mean clinical scores of TB patients (TBscore) at two tim
initial phase show significant difference; paired t-test (p < 0.001) N = 9used original instructions to score the BIPQ (Broadbent
et al. 2006) and TB score (Wejse et al. 2008). Bivariate cor-
relations among the clinical and BIPQ scores at different
time points were examined using Pearson’s Correlation
Coefficient (r). The existence of significant differences be-
tween clinical and BIPQ scores at different time points
was tested by corresponding paired t-tests. The signifi-
cance levels were set at 0.01 < p ≤ 0.05 (statistically signifi-
cant) and p ≤ 0.01 (highly statistically significant).
Results
The total of 167/178 patients with pulmonary TB and
valid questionnaires consisted of 104 (62.3%) men and
63 (37.7%) women of mean age 43.57 ± 14.462 years
(18–83, range). The mean clinical score (TBscore) was
4.79 ± 2.918 in 167 patients’ sample at the beginning of
treatment. In the sample of 93/167 patients retested at
2-month point the scores were 4.16 ± 2.871 and 2.41 ±
2.285 at time points 0 and 2, respectively (Figure 1), and
the findings were highly significantly different (paired
t-test, p < 0.001). The components of TB score results
are shown in Table 1.
Total mean BIPQ score was 36.25 ± 11.053 at the start
of treatment. We found close positive correlations be-
tween total mean BIPQ and TB scores at both time
points (p < 0.001, 2-tailed). Mean values for the BIPQ
items and their correlation with clinical score are pre-
sented in Table 2. The highest BIPQ item-related score
was found for treatment control and the lowest for time-
line (illness duration) and identity (Tables 2 and 3, and
Figure 2).e points: 0 - at the start of treatment and 2 - at the end of the
3.
Table 2 Mean values of BIPQ items and correlation with




1. Consequences 5.96 ± 3.144 0.072
2. Timeline 4.82 ± 2.775 0.103
3. Personal control 6.95 ± 2.780 −0.054
4. Treatment control 8.26 ± 2.464 −0.108
5. Identity 4.86 ± 2.877 0.268 <0.001
6. Concern 6.44 ± 2.949 0.084
7. Understanding 7.38 ± 2.751 −0.215 <0.001
8. Emotional response 6.62 ± 2.932 0.100
Total BIPQ score 36.25 ± 11.054 0.271 <0.001
BIPQ = Brief Illness Perception Questionnaire (Broadbent et al. 2006); TBscore
(Wejse et al. 2008).
The p-values are entered only where the correlation is significant.
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ues for total BIPQ score at the beginning of treat-
ment (0-month point) and the total score at the end
of the initial phase of therapy (2-month point); paired
samples test, 2-tailed, p < 0.001 (Table 3). Total BIPQ
scores at both time points are shown in Figure 3 for
93 patients.
The answers to the BIPQ open question on the main
causes of the illness by patients’ own opinion, showed
that stress, tobacco smoking and malnutrition were first
in the rank order. Only 25% of the patients stated a
germ or contact with another TB patient as the main
cause of the disease whatever the order was.
Analysis of the patients’ tobacco smoking status showed
104 (62.27%) active smokers at the time of diagnosis and
the proportion decreased only slightly during the course
of therapy.Table 3 The mean values of BIPQ item scores at the start of a
initial phase of treatment (2)
BIPQ item Mean value ± SD
(0)
N = 167
1. Consequences# 5.96 ± 3.144
2. Timeline 4.82 ± 2.775
3. Personal control 6.95 ± 2.780
4. Treatment control 8.26 ± 2.464
5. Identity# 4.86 ± 2.877
6. Concern# 6.44 ± 2.949
7. Understanding 7.38 ± 2.751
8. Emotional response# 6.62 ± 2.932
Total BIPQ score# 36.25 ± 11.054
#Significant difference between 0- and 2-month point (p < 0.01).The majority of patients would inform their family
and/or friends about their illness, but one third of them
would rather tell nobody.
Discussion
The original BIPQ, which we implemented in patients
with TB, allowed rapid assessment of illness perceptions
and took just a few minutes to complete. The patients’
perceptions of the disease varied widely. The over-all
BIPQ score is concordant with the clinical TB score at
the beginning of treatment, but significantly differed
from BIPQ mean values at the end of the initial phase of
therapy. This could be expected since higher BIPQ
scores indicate a more threatening view of the disease,
and higher TBscore indicates more severe clinical pres-
entation. The mean value of the total BIPQ score in the
current study is lower than that in a group of patients
with chronic obstructive pulmonary disease (COPD) but
higher than in those with allergic rhinitis assessed by the
same methodology (Pesut et al. 2010; Pesut et al. 2014).
This may suggest that TB is perceived as a less threaten-
ing disease than COPD. While COPD patients see the
BIPQ item, duration, as the most threatening, the results
of implementation of the BIPQ in TB patients may re-
flect positive effects of the efforts to describe TB as a
curable disease, i.e. a disease with a defined duration.
While a study in Bangladesh showed widespread belief
that TB is not curable (Karim et al. 2011), ours revealed
that TB patients believed in treatment (the highest and
significantly increasing score for treatment control). On
the other hand, the mean score for identity (experience
of symptoms correctly referred to TB) as one of the low-
est BIPQ scores suggests that further efforts are needed
to make TB less mysterious and confusing for patients.
Thus, TB patients recognized symptoms but were not
able to refer them to the illness itself. Furthermore, anti-tuberculosis therapy (0) and at the end of the
Mean value ± SD Mean value ± SD
(0) (2)
N = 93 N = 93
6.01 ± 2.958 5.03 ± 3.171
4.92 ± 2.700 5.12 ± 2.532
7.09 ± 2.831 7.43 ± 2.939
8.13 ± 2.950 8.32 ± 2.675 max
4.65 ± 2.842 3.85 ± 2.596
6.05 ± 2.983 4.66 ± 2.865
7.44 ± 2.984 7.66 ± 2.947
6.54 ± 2.865 4.55 ± 3.070 min
35.6237 ± 11.15203 29.795 ± 13.277
Figure 2 The mean values of BIPQ item scores at the start of anti-tuberculosis therapy (0) and at the end of the initial phase of
treatment (2) N = 93.
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understanding, and clinical score, as well as a significant
lack of patients’ knowledge about the main cause of TB.
The present findings have implications both for routine
clinical practice and for general plans for TB control
strategies in terms of an improved approach towards
education of patients and the population about TB as an
infectious disease and its clinical presentation. A new
TBNET project, ExplainTB, has been developed to meet
this purpose worldwide (TBNET Tuberculosis Network
European Trials Group 2014).
The majority of our TB patients were active smokers
at the time of diagnosis and many of them listed smok-
ing as the main cause of the disease. Tobacco smoking is
a major and the most preventable cause of morbidityFigure 3 Total BIPQ scores of TB patients at two time points: 0 - at thand mortality in the world (World Health Organization
2013; Slama, 2004). It has been shown to decrease both
cellular and humoral immunity in humans (Sopori, 2002;
Arcavi and Benowitz 2003; Bates et al. 2007). Its associ-
ation with TB was the focus of several studies, which dem-
onstrated its influence on the severity and clinical course
of the disease, and indicated an increased rate of TB re-
lapses in smokers (Bates et al. 2007; Bothamley, 2005).
Apart from education on the harmful effects of tobacco
smoking and its association with TB, proper professional
help in smoking cessation should be offered to those TB
patients who are not able to quit smoking alone.
The finding that one third of the patients would not
tell anybody about their illness, might suggest that fear
of social exclusion still exists (Story et al. 2006) ande start of treatment and 2- at the end of the initial phase N = 93.
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Suleiman et al. 2013).
Instead of the long and time consuming Illness Percep-
tion Questionnaire - IPQ (or its revised version IPQ-R),
we have used the equally valid BIPQ (Broadbent et al.
2006) to record patients’ personal beliefs about TB. An ad-
vantage of this approach was that we were able to obtain
initial information from almost all patients in successive
series, including severely ill ones, thus excluding a po-
tential selection bias. The study design enabled us to ob-
tain a general picture of illness perception in TB quickly
and to identify rapidly the particular results of the test for
each patient. We could also identify the highest and the
lowest BIPQ item scores in the study group, which in-
cluded double the number suggested to be necessary
(Bean et al. 2007). We could not obtain uniform follow
up and data collection to maintain all the enrolled pa-
tients’ longitudinal data by closure of the study, so there
was a decrease in the number patients at the 2-month
point. This was not related to their condition but to no-
tification problems and data collection. However, the
paired t-test analysis showed increased emotional stability
and control over time when the patients apparently gained
increased control over their illness, increased believe in
the treatment with decreasing symptoms. The emotional
response scores were inverse to the illness identity scores
and disease control scores at the two time points.
Assessment of illness perception in routine clinical
practice could address problems in patients’ behavior
that may disturb adherence to treatment and lead to de-
fault (Hasker et al. 2008). Since illness perceptions can
be changed, the results of our study have potential utility
in intervention design and health promotion.Conclusion
This study represents the first assessment of illness
perception in TB by implementation of the Brief Ill-
ness Perception Questionnaire – BIPQ. The 9-item ques-
tionnaire allows rapid assessment of illness perception,
especially of its cognitive and emotional aspects. Illness
perception in TB shows wide variability and a positive
correlation with clinical disease score. The results show
that TB patients believe in treatment but also indicate
further need of education aimed to make TB causes
clear and illness identity less confusing. The fact that
cohort had a high proportion of smokers that failed to
quit smoking during the treatment indicates that more
efforts to stop smoking are warranted. Implementation
of the BIPQ in routine practice would allow better un-
derstanding of patients’ behavior that could lead to de-
fault and drug resistance. Further study is needed to
investigate the influence of illness perception on treat-
ment outcome in TB.Additional file
Additional file 1: The Brief Illness Perception Questionnaire.
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